EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, HOWL: Werewolf Therapeutics Inc

24 Dec 25 09:35
LAST:

0.6466

CHANGE:
 0.02		OPEN:
0.6352		HIGH:
0.6850		ASK:
0.0000		VOLUME:
15.1K
CHG(%):
2.85		PREV:
0.6287		LOW:
0.6352		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Dec 250.63520.68500.63520.646615.1K
23 Dec 250.66000.68800.61000.62871.32M
22 Dec 250.70000.75680.65800.66941.03M
19 Dec 250.65800.72000.65480.68681.25M
18 Dec 250.80000.80000.55880.64666.26M
17 Dec 251.11001.20001.06001.0700470.7K
16 Dec 251.02001.10001.02001.0800269.3K
15 Dec 251.10001.11981.02001.0300404.1K
12 Dec 251.10001.10001.06001.1000376.8K
11 Dec 251.09001.11001.04041.0900457.1K

PROFILE

Name:Werewolf Therapeutics Inc
About:Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:200 Talcott Ave, Watertown, MA, United States, 02472
Website:https://werewolftx.com
CUSIP:95075A107
CIK:0001785530
ISIN:US95075A1079
FIGI:BBG00QXQ9XK4

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.80 
Forward P/E:-0.72 
PEG Ratio:-0.72 
Price to Sales:31.78 
Price to Book:1.43 
Operating Margin:-34.94 
Return on Assets:-0.37 
Return on Equity:-1.01 
EPS Ratio:-1.64 
Revenue:1.89M 
Shares:45.73M 
Market Cap:29.57M 

TECHNICAL INDICATORS

MA5:0.662.6%
MA10:0.8734.3%
MA20:0.9242.2%
MA50:1.1475.8%
MA100:1.33105.9%
MA200:1.2187.3%
STO9:9.85 
STO14:9.85 
RSI14:32.72 
WPR14:-88.05 
MTM14:-0.27
ROC14:-0.28 
ATR:0.11 
Week High:1.2085.6%
Week Low:0.5615.7%
Month High:1.2085.6%
Month Low:0.5687.3%
Year High:2.38268.1%
Year Low:0.5615.7%
Volatility:48.92